Although the use of NOTA provides stable coupling of 64Cu [45], earlier studies on 64Cu-labeled anti-HER2 affibody molecules have shown that the renal metabolism of such tracers after reabsorption in the proximal tubuli causes a release of 64Cu into the blood stream, decreasing the tumor-to-blood ratio [46]. This evidence concerns the gene ERBB2 and neoplasm.